ZA922721B - 1-(pyrido(3,4.b)-1,4-oxazinyl-4-yl)-1h-indoles,intermediates and a process for their preparation,and their use as medicaments - Google Patents

1-(pyrido(3,4.b)-1,4-oxazinyl-4-yl)-1h-indoles,intermediates and a process for their preparation,and their use as medicaments

Info

Publication number
ZA922721B
ZA922721B ZA922721A ZA922721A ZA922721B ZA 922721 B ZA922721 B ZA 922721B ZA 922721 A ZA922721 A ZA 922721A ZA 922721 A ZA922721 A ZA 922721A ZA 922721 B ZA922721 B ZA 922721B
Authority
ZA
South Africa
Prior art keywords
loweralkyl
hydrogen
medicaments
chem
oxazinyl
Prior art date
Application number
ZA922721A
Other languages
English (en)
Inventor
Richard C Effland
C Effland Richard
Larry Davis
Davis Larry
Gordon E Olsen
E Olsen Gordon
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA922721B publication Critical patent/ZA922721B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA922721A 1991-04-15 1992-04-14 1-(pyrido(3,4.b)-1,4-oxazinyl-4-yl)-1h-indoles,intermediates and a process for their preparation,and their use as medicaments ZA922721B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/684,758 US5214038A (en) 1991-04-15 1991-04-15 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof

Publications (1)

Publication Number Publication Date
ZA922721B true ZA922721B (en) 1992-11-25

Family

ID=24749434

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922721A ZA922721B (en) 1991-04-15 1992-04-14 1-(pyrido(3,4.b)-1,4-oxazinyl-4-yl)-1h-indoles,intermediates and a process for their preparation,and their use as medicaments

Country Status (22)

Country Link
US (3) US5214038A (cs)
EP (1) EP0509400B1 (cs)
JP (1) JP2608359B2 (cs)
KR (1) KR100201509B1 (cs)
AT (1) ATE140006T1 (cs)
AU (1) AU643135B2 (cs)
CA (1) CA2065986C (cs)
CZ (1) CZ282054B6 (cs)
DE (1) DE69211892T2 (cs)
DK (1) DK0509400T3 (cs)
ES (1) ES2094840T3 (cs)
FI (1) FI97544C (cs)
GR (1) GR3020612T3 (cs)
HU (1) HUT62588A (cs)
IE (1) IE74907B1 (cs)
IL (1) IL101589A (cs)
NO (1) NO301765B1 (cs)
NZ (2) NZ248131A (cs)
PL (1) PL168671B1 (cs)
RU (1) RU2042680C1 (cs)
TW (1) TW211016B (cs)
ZA (1) ZA922721B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360811A (en) * 1990-03-13 1994-11-01 Hoechst-Roussel Pharmaceuticals Incorporated 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
WO2003022813A1 (en) * 2001-09-07 2003-03-20 Ono Pharmaceutical Co., Ltd. Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
MX2011007864A (es) 2009-01-28 2011-09-30 Karus Therapeutics Ltd Isosteros para realzar la transcripcion y su uso en terapia.
ES2672701T3 (es) * 2012-11-07 2018-06-15 Karus Therapeutics Limited Nuevos inhibidores de histona deacetilasa y su uso en terapia
KR20160007577A (ko) 2013-05-10 2016-01-20 카루스 떼라퓨틱스 리미티드 신규한 히스톤 디아세틸라제 억제제들
GB201419264D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
GB201419228D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
FI3837263T3 (fi) 2018-08-13 2024-09-03 Hoffmann La Roche Uusia heterosyklisiä yhdisteitä monoasyyliglyserolilipaasin estäjinä
JP7444882B2 (ja) 2018-11-22 2024-03-06 エフ． ホフマン－ラ ロシュ アーゲー 新規の複素環化合物
PE20220565A1 (es) 2019-09-12 2022-04-13 Hoffmann La Roche Compuestos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inhibidores de magl

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029657A (en) * 1976-06-14 1977-06-14 The Dow Chemical Company 6,7-Dichloro-3,4-dihydro-2H-pyrazino(2,3-B)(1,4)oxazines
DE2726437A1 (de) * 1977-06-11 1978-12-21 Bayer Ag Hydrazonfarbstoffe
US5039811A (en) * 1987-04-24 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-(pyridinyl)-1H-indol-1-amines
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
NZ234726A (en) * 1989-08-02 1992-01-29 Hoechst Roussel Pharma 2,3-dihydro-1-(pyridinylamino)-indoles and pharmaceutical compositions
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines

Also Published As

Publication number Publication date
US5276156A (en) 1994-01-04
TW211016B (cs) 1993-08-11
DE69211892T2 (de) 1996-12-19
NZ248131A (en) 1995-07-26
EP0509400B1 (en) 1996-07-03
NO921490D0 (no) 1992-04-14
CS113592A3 (en) 1992-11-18
PL294221A1 (en) 1993-08-09
PL168671B1 (pl) 1996-03-29
NZ242309A (en) 1995-07-26
FI97544C (fi) 1997-01-10
HU9201290D0 (en) 1992-07-28
HUT62588A (en) 1993-05-28
NO921490L (no) 1992-10-16
JPH05112572A (ja) 1993-05-07
US5519131A (en) 1996-05-21
IE74907B1 (en) 1997-08-13
DK0509400T3 (da) 1996-10-28
ATE140006T1 (de) 1996-07-15
FI921641A0 (fi) 1992-04-13
KR100201509B1 (ko) 1999-06-15
NO301765B1 (no) 1997-12-08
AU643135B2 (en) 1993-11-04
RU2042680C1 (ru) 1995-08-27
CZ282054B6 (cs) 1997-05-14
IL101589A0 (en) 1992-12-30
US5214038A (en) 1993-05-25
FI921641A7 (fi) 1992-10-16
JP2608359B2 (ja) 1997-05-07
CA2065986C (en) 2006-02-21
EP0509400A1 (en) 1992-10-21
FI97544B (fi) 1996-09-30
IL101589A (en) 1996-10-31
GR3020612T3 (en) 1996-10-31
DE69211892D1 (de) 1996-08-08
AU1485292A (en) 1992-10-22
KR920019796A (ko) 1992-11-20
IE921190A1 (en) 1992-10-21
CA2065986A1 (en) 1992-10-16
ES2094840T3 (es) 1997-02-01

Similar Documents

Publication Publication Date Title
IL101589A0 (en) 1-(pyrido(3,4,b)-1,4-oxazinyl-4-yl)-1h-indoles,intermediates and a process for their preparation,and their use as medicaments
NZ221543A (en) 4-aminoquinoline derivatives and pharmaceutical compositions containing such
NZ235460A (en) Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl-carbamate derivatives and pharmaceutical compositions
IL102118A0 (en) ((arylalkylpiperidin-4-yl)methyl)-2a,3,4,5-tetrahydro-1(2h)-acenaphthylen-1-ones and related compounds,a process for their preparation and their use as medicaments
AU8121691A (en) 1-(substituted pyridinylamino)-1h-indole-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments
DE3780015D1 (de) Kondensierte heterocyclische tetrahydroaminochinolinole und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
AU590748B2 (en) Benzo(C)-1,5-naphthyridines, a process and intermediates for their preparation and their use as medicaments
ZA904442B (en) 4,5,5a,6-tetrahydro-3h-isoxazolo(5,4,3-kl)acridines derivatives,a process for their preparation and their use as medicaments